SynthesisJournal of vascular and interventional radiology : JVIR2020
Transjugular Renal Biopsy Bleeding Risk and Diagnostic Yield: A Systematic Review.
Synthesis in Journal of vascular and interventional radiology : JVIR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Ultrasound-guided percutaneous renal biopsy: Free-hand versus puncture attachment.The Journal of international medical research · 2026Article
- Transjugular liver biopsy in patients with unexplained liver dysfunction and bleeding tendency: a safety and efficacy analysis.BMC gastroenterology · 2026Article
- Percutaneous endovascular biopsy for the diagnosis of intravascular masses: a single-center retrospective study.Frontiers in medicine · 2026Article
- Fluoroscopy-guided transvenous femoral renal transplant biopsies: a monocentric retrospective study about 109 consecutive patients.La Radiologia medica · 2025Article
- Identification of M2 macrophage-related biomarkers for a predictive model of interstitial fibrosis and tubular atrophy after kidney transplantation by machine learning algorithms.Translational andrology and urology · 2025Article
- Predictive and diagnostic value of MCP-1, MIF, and ICAM-1 in Type-2 diabetes mellitus patients with diabetic kidney disease.Pakistan journal of medical sciences · 2025Article
- Exploring alternatives to laparoscopic renal biopsy: a critical examination of safety, efficacy, and costs.Renal failure · 2024Article
- Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety.Journal of clinical medicine · 2023Review
- Safety of Obtaining an Extra Biobank Kidney Biopsy Core.Journal of clinical medicine · 2022Article
- Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis.Journal of immunology research · 2022Article
- Major Bleeding of Transjugular Native Kidney Biopsies. A French Nationwide Cohort Study.Kidney international reports · 2021Article
- Transjugular Kidney Biopsy as a Safe Method to Increase the Etiological Diagnosis in Kidney Disease.Kidney international reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aimed to better define the safety and efficacy of transjugular renal biopsy (TJRB) based on published studies. Seventeen published articles were included (1,321 biopsies). Complications were classified as major if they resulted in blood transfusion or additional invasive procedures. All other bleeding complications were considered minor. Diagnostic tissue was obtained in 1,193 procedures (90.3%). The total incidence of bleeding complications among 15 articles with complete data was 202 of 892 procedures (22.6%): 162 (18.2%) minor and 40 (4.5 %) major. These results show that TJRB is a feasible procedure for obtaining renal tissue for diagnosis and that most complications are self-limiting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.